
CONMED Corporation CNMD
$ 39.24
-1.26%
Annual report 2025
added 02-17-2026
CONMED Corporation Total Non Current Liabilities 2011-2026 | CNMD
Annual Total Non Current Liabilities CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 877 M | 546 M | 577 M | 634 M | 408 M | 401 M | 373 M | 355 M | 231 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 877 M | 231 M | 489 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
184 M | $ 186.99 | 1.25 % | $ 14 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 12.65 | -0.98 % | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 297.14 | 1.6 % | $ 8.38 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.54 | 5.04 % | $ 133 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 39.58 | -0.8 % | $ 5.9 K | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 64.53 | 1.13 % | $ 95.5 B | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.6 | 1.32 % | $ 37.3 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 1.96 | -1.01 % | $ 1.19 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.45 | 0.67 % | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Inogen
INGN
|
52.5 M | $ 6.3 | -0.71 % | $ 168 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
8.87 K | $ 25.75 | 1.78 % | $ 218 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.02 | -0.49 % | $ 17.3 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
LENSAR
LNSR
|
3.44 M | $ 6.19 | 2.48 % | $ 74 M | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 94.86 | -0.07 % | $ 12.8 B | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.9 | 0.22 % | $ 420 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Myomo
MYO
|
275 K | $ 0.79 | 1.42 % | $ 33.1 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.96 | 0.74 % | $ 393 M | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 56.77 | -0.16 % | $ 1.67 B | ||
|
LivaNova PLC
LIVN
|
516 M | $ 65.08 | 0.14 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 87.37 | -1.4 % | $ 3.03 B | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.76 | - | $ 123 M | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 78.15 | -0.06 % | $ 45.7 B | ||
|
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M |